News
Ozempic ® is the only GLP-1 RA that has proven risk reduction of cardiovascular and kidney events in people with type 2 diabetes 3-6. These results provide the first direct comparison of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback